Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
61 Cards in this Set
- Front
- Back
Acetylcholine |
will activate nicotinic and muscarinic receptors Ach Agonist |
|
Methacholine |
1)Ach Agonist 2)will only activate muscarinic receptors 3)used diagnostically for bronchial hypersensitivity |
|
Carbachol |
1)Ach Agonist 2)resistant to AchE 3)used for wide-angle glaucoma |
|
Bethenechol |
1)Ach Agonist 2)will only stimulate muscarinic receptors 3)resistant to AchE 4)bladder distention (increases it) |
|
Pilocarpine |
1)Ach Agonist 2)can cross into the CNS 3)wide angle glaucoma |
|
Edrophonium |
1)anticholinesterase 2)reversible 3)used diagnostically to test for myasthenia gravis |
|
Physostigmine |
1)anticholinesterase 2)reversible 3)carbamate 4)used for glaucoma 5)adverse effects: cataracts |
|
Neostigmine |
Anticholinesterase 1)reversible 2)carbamate 3)reverses NMJ block 4)used for myesthenia gravis |
|
Pyridostigmine |
1)Anticholinesterase 2)reversible 3)carbamate 4)used for myesthenia gravis *same as Neostigmine, but better because has a longer half life |
|
Denepezil |
1)Anticholinesterase 2)reversible 3)used for Alzheimers |
|
Echothiopate |
1)Anticholinesterase 2)irreversible 3)organophosphate (only clinically useful organophophate, others are toxic pesticides) 4)glaucoma |
|
Succinylcholine |
Neuromuscular (NMJ) Blocking Drug 1)depolarizing (two phases) 2)metabolized by: plasma cholinesterase 3)rapid onset 4)side effects: apnea, hyperkalemia, inc intraocular/gastricP, hyperthermia 5)not used for children |
|
Mivacurium |
Neuromuscular (NMJ) Blocking Drug 1)nondepolarizing 2)rapid onset 3)metabolized by: plasma cholinesterase 4)side effect: histamine release |
|
Rocuronium |
Neuromuscular (NMJ) Blocking Drug 1)nondepolarizing 2)rapid onset 3)metabolized by liver 4)*second best if succinylcholine is not an option |
|
Vecuronium |
Neuromuscular (NMJ) Blocking Drug 1)nondepolarizing 2)metabolized by liver 3)intermediate duration |
|
Cis-atracurium |
Neuromuscular (NMJ) Blocking Drug 1)nondepolarizing 2)intermediate duration 3)metabolized by spontaneous hydrolysis 4)concern for hypotension and bronchoconstriction |
|
Pancuronium |
Neuromuscular (NMJ) Blocking Drug 1)nondepolarizing 2)long duration 3)metabolized by kidney 4)side effect: tachycardia |
|
Atropine |
Anticholinergic 1)inhibit all mAchR, will see SNS effects 2)long last pupil dilation 3)used to reverse effects of AchE inhibitors 4)antidiarrheal |
|
Scopolamine |
Anticholinergic 1)inhibits all mAchR 2)used for motion sickness 3)side effect: drowsiness |
|
Tropicamide |
Anticholinergic 1)inhibits all mAchR 2)fast and short acting pupil dilator |
|
Ipratropium |
Anticholinergic 1)inhibits all mAchR 2)used for COPD (bronchodilation) |
|
Tolterodine |
Anticholinergic 1)inhibits all mAchR 2)used for overactive bladder 3)side effects: dry mouth and blurred vision 4)contraindication: narrow angle glaucoma |
|
Dicyclomine |
Anticholinergic 1)inhibits GI mAchR 2)used for irritable bowel syndrome |
|
Glycopyrrolate |
Anticholinergic 1)inhibits all mAchR 2)decreases secretions and sweating 3)used to prevent muscarinic side effects if given Neostigmine (or other AchE inhibitor) |
|
Hexamethonium |
Anticholingergic 1)inhibits nictonic AchR 2)prevents baroreceptor reflex 3)no clinical use |
|
Mecamylamine |
Anticholinergic 1)inhibits nicotinic AchR 2)improves GI absorption 3)tourettes syndrome 4)no clinical use |
|
Norepinephrine (NE) |
Adrenergic Agonist 2)potent vasoconstrictor (a1) 3)used for shock and hypotension |
|
Epinephrine (Epi) |
Adrenergic Agonist 1)will activate all receptors (a1, a2, b1, b2) 2)at low concentrations, will activate more B than A 3)used for anaphylactic shock 4)prolongs effects of local anesthetics 5)used for cardiac arrest 6)used to decrease bleeding during surgery |
|
Dopamine |
Adrenergic Agonist 1)renal dilation (D1) 2)used to treat cardiogenic, septic, and hypovolemic shock |
|
Phenylephrine |
Adrenergic Agonist 1)A1 2)dilates eye without paralyzing ciliary muscle (no accomodatoin) 3)nasal decongestant 4)used for: hypotension and paroxysmal atrial tachycardia |
|
Methoxamine |
Adrenergic Agonist 1)A1 2)orthostatic hypotension 3)paroxysmal atrial tachycardia |
|
Clonidine |
Adrenergic Agonist 1)A2 2)used for hypertension 3)decreases SNS activity, so decreases BP 4)help with opiate withdrawal symptoms 5)apraclonidine: used for glaucoma |
|
Dobutamine
|
Adrenergic Agonist 1)B1 2)acute heart failure and cardiogenic shock 3)ionotrope (increases force of heart) |
|
Isoproterenol |
Adrenergic Agonist 1)B1 and B2 2)asthma 3)cardiac stimulation (b1) and bronchodilation (b2) 4)not drug of choice (DOC) for anything |
|
Albuterol |
Adrenergic Agonist 1)B2 2)bronchodilation 3)asthma, COPD, bronchitis |
|
Metaproterenol |
Adrenergic Agonist 1)B2 2)bronchodilation 3)asthma, COPD, bronchitis |
|
Terbutaline |
Adrenergic Agonist 1)B2 2)uterine relaxation and bronchodilation 3)used for: asthma and premature labor |
|
Ritodrine: |
Adrenergic Agonist 1)B2 2)uterine contraction and bronchodilation 3)used for: asthma and premature labor |
|
Salmeterol |
Adrenergic Agonist 1)B2 2)long-lasting 3)asthma |
|
Ephedrine |
Adrenergic Agonist 1)indirect stimulator of NE 2)decongestant 3)CNS stimulation |
|
Pseudoephedrine |
Adrenergic Agonist 1)indirect stimulator of NE 2)decongestant 3)CNS stimulation |
|
Amphetamine |
Adrenergic Agonist 1)indirect stimulator of NE 2)stimulant 3)ADHD 4)narcolepsy |
|
Cocaine |
Adrenergic Agonist 1)increases NE and dopamine (by inhibiting reuptake of both) 2)analogues are used as a local anesthetic |
|
Tyramine |
Adrenergic Agonist 1)indirectly leads to increase in NE 2)no use 3)can cause hypertensive crisis |
|
Phenoxybenzamine |
Adrenergic Antagonist 1)A1 and A2 2)irreversible 3)decreases BP if high bc of SNS overstimulation (useful for Pheochromocytoma) 4)used to treat vasospasm in peripheral circulation (Raynaud's Phenomenon) 5)side effect: tachycardia |
|
Phentolamine |
Adrenergic Antagonist 1)A1 and A2 2)erectile dysfunction (part of a mixture of drugs) 3)hypertensive emergencies 4)side effect: tachycardia |
|
Prazosin |
Adrenergic Antagonist 1)A1 2)used for mild hypertension and benign prostatic hyperplasia (BPH) 3)used to treat vasospasm in peripheral circulation (Raynaud's Phenomenon) 4)side effect: orthostatic hypotension |
|
Doxazosin / Terazosin |
Adrenergic Antagonist 1)A1 2)similar to prazosin, but longer half life 3)used for hypertension and BPH |
|
Tamsulasin |
Adrenergic Antagonist 1)A1 (in prostate) 2)used for BPH 3)no significant effect on BP |
|
Yohimbine |
Adrenergic Antagonist 1)A2 2)not widely used 3)impotence |
|
Propranolol |
Adrenergic Antagonist 1)B1 and B2 2)used for: ischemic heart disease, angina, hypertension, arrythmia, etc. 3)lipid soluble (can enter CNS) 4)Membrane Stabilizing Action (MSA): block Na+ channels, at high level will inc QRS and have prob with cardiac conduction |
|
Timolol |
Adrenergic Antagonist 1)B1 and B2 2)glaucoma 3)ischemic heart disease |
|
Nadolol |
Adrenergic Antagonist 1)B1 and B2 2)long lasting 3)hypertension *Similar to propranolol, but with longer half life |
|
Atenolol |
Adrenergic Antagonist 1)B1 2)low lipid solubility, can't enter CNS 3)hypertension (widely used) 4)bc it's B1 selective, better for patients with bronchoconstriction problem |
|
Metoprolol |
Adrenergic Antagonist 1)B1 2)high lipid solubility, can enter CNS 3)ischemic heart disease, hypertension 4)MSA (membrane stabilizing action) |
|
Esmolol |
Adrenergic Antagonist 1)B1 2)very short acting 3)used for intraoperative and postoperative hypertension |
|
Pindolol |
Adrenergic Antagonist 1)B1 and B2 2)ISA-partial agonist (intrinsic sympathomimetic activity) 3)MSA 4)hypertension with less bradycardia |
|
Acebutolol |
Adrenergic Antagonist 1)B1 2)ISA-partial agonist 3)hypertension with less bradycardia |
|
Labetolol |
Adrenergic Antagonist 1)B1, B2, A1 2)severe hypertension |
|
Carvedilol |
Adrenergic Antagonist 1)B1, B2, mild A1 2)CHF, hypertension 3)moderate heart failure |
|
Pharmacokinetic Equations |
1)Vd=dose/C0 C0=concentration at t=0 2)t1/2=(.693*Vd)/(CL) CL=clearance 3)infusion rate=CL*Css Css=steady state, desired concentration 4)deltaC=dose/Vd deltaC=increase in plasma conc of the drug |